In vitro and in vivo effects of corticosteroids on peripheral blood lymphocytes from ponies.

This research paper studies the effects of corticosteroids, specifically Prednisolone, on the blood lymphocytes in ponies, both in a lab setting (in vitro) and while inside of a pony (in vivo).

Introductory Context

• The research aimed to investigate the impact of corticosteroids on peripheral blood lymphocytes (PBL) in ponies in both controlled lab environments (in vitro) and within the pony body (in vivo).

Experiments and Findings

• This study revealed that Prednisolone, a type of corticosteroid, was able to slow down the lymphocyte stimulation process by reacting with Phytohemagglutin (PHA) in the case of both normal ponies and horses with a combined immunodeficiency trait.
• At the same time, the research showed Prednisolone did not cause lysis, a kind of cell destruction, even when administered in large amounts.
• When the corticosteroids were removed after a period of incubation, the natural reaction of the PBL to PHA was partially restored, making them active again.

Chronic In-Vivo Results

• Long-term use of corticosteroids in real-life conditions (chronic in vivo) resulted in a significant drop in the total number of circulating lymphocytes in ponies.
• However, most of the remaining lymphocytes maintained their surface immunoglobulin and C3 receptors, pointing to a major decrease in the T-lymphocyte population.

Post Treatment Responses

• Despite the decrease in T-lymphocytes, there was minimal change in the in vitro reactions of the lymphocytes to PHA (a plant protein) or Keyhole Limpet Hemocyanin (an animal protein) in the sensitized ponies.
• Overall, the effects of corticosteroids on the lysis, mitogenic stimulation (cell division), and antigenic responses (immune responses) to PBL from ponies were found to be in line with the earlier results obtained from human lymphocytes.